In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor

Neurological Surgery

Volumn 26, Issue 9, 1998, Pages 787-794

  Nakagawa, Hidemitsu ^a   Yamada, Masanobu ^e   Fukushima, Masakazu ^b   Shimizu, Keiji ^c   Ikenaka, Kazuhiro ^d  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Cancer Research Laboratory

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^e NONE

Author keywords

Brain tumor; Fluorodeoxyuridine; Intrathecal chemotherapy; Thymidine phosphorylase

Indexed keywords

FLOXURIDINE; FLUOROURACIL; THYMIDINE PHOSPHORYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG METABOLISM; GLIOBLASTOMA; INTRATHECAL DRUG ADMINISTRATION; LUNG CANCER; MEDULLOBLASTOMA; MENINGIOMA; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; CARCINOMA 256, WALKER; FLOXURIDINE; FLUOROURACIL; GLIOMA; HUMANS; INJECTIONS, SPINAL; MICE; MICE, INBRED C57BL; RATS; THYMIDINE KINASE; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED;

EID: 0031755923     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Birnie GD, Kroeger H, Heidelberger C: Studies of fluorinated pyrimidines. XVIII. The degradation of 5-fluoro-2′-deoxyuridine and related compounds by nucleoside phosphorylase. Biochemistry 2: 566-572, 1963
2. Bosch L, Harbers E, Heidelberger C: Studies on fluorinated pyrimidines. V. effects on nucleic acid metabolism in vitro. Cancer Res 18: 335-343, 1958
3. Bryan P: CSF seeding of intracranial tumors: a study of 96 cases. Clin Radiol 25: 355-360, 1974
4. Cohen SS, Flaks JG, Barner HD, Loeb MR, Lichtenstein J: The mode of action of 5-fluorouracil and its derivatives. Proc Natl Acad Sci USA 44: 1004-1012, 1958
5. Conroy T, Geoffrois L, Guillemin F, Luporsi E, Krakowski I, Spaëth D, Frasie V, Volff D: Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma. Cancer 72: 2190-2197, 1993
6. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973
7. Giannone L, Greco FA, Hainsworth JD: Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol 4: 68-73, 1986
8. Hartmann K-U, Heidelberger C: Studies on fluorinated pyrimidines XIII: inhibition of thymidylate synthetase. J Biol Chem 236: 3006-3013, 1961
9. Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44: 472-485, 1985
10. Kanzawa F, Hoshi A, Kuretani K: Differences between 5-fluoro-2′-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems. Eur J Cancer 16: 1087-1092, 1980
11. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastasis from colorectal carcinoma: a randomized trial. Ann Int Med 107: 459-465, 1987
12. Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Budd A: Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 11: 330-335, 1993
13. Kodama K, Doi O, Higashiyama M, Yokouchi H, Nakagawa H, Mori Y: Surgery for brain metastases from nonsmall cell lung carcinomas and tissue cultures from the resected specimens. J Surg Oncol 57: 121-128, 1994
14. Koenig H: Neurological action of some pyrimidine analogs. In: Pfeif fer CC, Smythies JR (eds). International Review of Neurobiology, Academic Press Inc. New York, 1967, vol 10, pp199-230
15. Koenig H, Patel A: Biochemical basis for fluorouracil neurotoxicity. Arch Neurol 23: 155-160, 1970
16. Laskin JD, Evans RM, Slocum HK, Burke D, Hakala MT: Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture. Cancer Res 39: 383-390, 1976
17. Maehara Y, Nakamura H, Nakane Y, Kawai K, Okamoto M, Nagayama S, Shirasaka T, Fujii S: Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues. Gann 73: 289-298, 1982
18. Marsh JC, Durivage HJ, Davis C, O'Hollaren K, Pasquale DN, Simonich, SA, Voynick IM, Bertino JR: Phase II study of pulse 5-fluoro-2′-deoxyuridine and leucovorin in advanced colorectal cancer patients previously treated with chemotherapy. Am J Clin Oncol 15: 115-118, 1992
19. Muller TJ, Shin KH, Shin DH: The murine ependymoblastoma: growth pattern and survival in C57BL/6J mice. Can J Neurol Sci 10: 105-109, 1983
20. Nakagawa H, Murasawa A, Kubo S, Nakajima S, Nakajima Y, Izumoto S, Hayakawa T: Diagnosis and treatment of patients with meningeal carcinomatosis. J Neuro-Oncol 13: 81-89, 1992
21. Norrell H, Wilson CB, Slagel DE, Clark DB: Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors. Cancer 33: 923-932, 1974
22. Okeda R, Shibutani M, Matsuo T, Kuroiwa T, Shimaoka R, Tajima T: Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and α -fluorβ -alanine. Acta Neuropathol 81: 66-73, 1990
23. Page KA, Vogel H, Horoupian DS: Intracerebral (parenchymal) infusion of methotrexate: report of a case. J Neuro-Oncol 12: 181-186, 1992
24. Park TS, Hoffman HJ, Hendrick EB, Humphreys RP, Becker LK: Medulloblastoma: clinical presentation and management: experience at the Hospital For Sick Children, Toronto, 1950-1980. J Neurosurg 58: 543-552, 1983
25. Parker WB, Cheng YC: Metabolism and mechanism of action of 5-fluorouracil. Pharmac Ther 48: 381-395, 1990
26. Roemeling RV, Rabatin JT, Fraley EE, Hrushesky WJM: Progressive metastatic renal cell carcinoma controlled by continuous 5-fluoro-2-deoxyuridine infusion. J Urol 139: 259-262, 1988
27. Roosa RA, Bradley TD, Law LW, Herzenberg LA: Characterization of resistance to amethopterin, 8-azaguanine and several fluorinated pyrimidines in the murine lymphocytic neoplasm, P388. J Cell Comp Physiol 60: 109-126, 1962
28. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Audy JCR, Gallot D, Gouzi JL, Pailler JL, Elisa D, Lacaine F, Roos S, Ratman N, Luboinski M, Lasser P: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10: 1112-1118, 1992
29. Sawa H, Takeshita I, Kuramitsu M, Mannoji H, Machi T, Fukui M, Kitamura K: Neuronal and glial proteins in medulloblastomas. I. immunohistochemical study. Anticancer Res 6: 905-910, 1986
30. Somrnadossi J-P, Aubert C, Jacquet C, Iliadis A, Cano J-P: The pharmacology and metabolism of 5′-deoxy-5-fluorouridine. In "Fluoropyrimidines in Cancer Therapy," ed. Kimura K, Fujii S, Ogawa M, Bodey GP, Alberto P, pp.108-120, Excerpta Medica, Amsterdam, New York, 1984
31. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumor: experience with 90 patients. Cancer 49: 759-772, 1982